University of Texas at Austin
Austin, Texas, United States
Purpose
to identify potent anti-RSV monoclonal antibodies to protect infants in low and middle income countries from RSV infection morbidity and mortality
Division
Global Health
Date
November 2022
Region Served
GLOBAL
Committed amount
$177,841
Grant topic
Discovery and Translational Sciences, Pneumonia & Pandemic Preparedness
Duration (months)
31
Grantee location
Austin, Texas, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.